KR0140323B1 - PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID - Google Patents

PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID

Info

Publication number
KR0140323B1
KR0140323B1 KR1019940040275A KR19940040275A KR0140323B1 KR 0140323 B1 KR0140323 B1 KR 0140323B1 KR 1019940040275 A KR1019940040275 A KR 1019940040275A KR 19940040275 A KR19940040275 A KR 19940040275A KR 0140323 B1 KR0140323 B1 KR 0140323B1
Authority
KR
South Korea
Prior art keywords
amino acid
compound
alkyl
formula
group
Prior art date
Application number
KR1019940040275A
Other languages
Korean (ko)
Other versions
KR960022447A (en
Inventor
정성기
강동호
정태흠
Original Assignee
김만제
포항종합제철주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김만제, 포항종합제철주식회사 filed Critical 김만제
Priority to KR1019940040275A priority Critical patent/KR0140323B1/en
Publication of KR960022447A publication Critical patent/KR960022447A/en
Application granted granted Critical
Publication of KR0140323B1 publication Critical patent/KR0140323B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms

Abstract

일반식General formula

(I)로 나타내어지는 광활설 α-아미노산 제조방법이 제공된다.There is provided a method for producing a wide active α-amino acid represented by (I).

본 발명의 방법에서는 프롤린이나 그 유사체를 키랄보조기로 사용하여 광활성을 갖는 α-아미노산을 높은 수율로 제조한다.In the method of the present invention, α-amino acid having photoactivity is produced in high yield using proline or an analog thereof as a chiral assistant.

이방법은 일반식This method is a general formula

의 화합물을 친전자체시약과 반응시켜 아미도고리화시킨 후, 그 결과 생성된 물질을 환원시켜 친전자체 기능기를 제거하고, 산성조건하에서 가수분해시켜 α-아미노산을 얻는다.The compound of is reacted with an electrophilic reagent to undergo amido ring, and the resulting material is reduced to remove electrophilic functional groups and hydrolyzed under acidic conditions to obtain α-amino acid.

단, 상기 식에서 A=B=H이거나, A-X-B부분이 포화되었거나 불포화된 접합된 탄소고리화합물이거나 헤테로고리화합물이며, R은 알킬 또는 아릴기이며, Y는 -CONH2, C≡N, CONHNH2, CON3, CONHSO2R'(단, R'는 알킬 또는 아릴이다), 또는 CONHOR(단 R는 알킬 또는 Cbz이다)이며, α위치의 입체화학은 R 또는 S에 해당된다.Provided that A = B = H, wherein the AXB moiety is a saturated or unsaturated conjugated carbon ring compound or heterocyclic compound, R is an alkyl or aryl group, Y is -CONH 2 , C≡N, CONHNH 2 , CON 3 , CONHSO 2 R ′ (where R ′ is alkyl or aryl), or CONHOR (where R is alkyl or Cbz), and the stereochemistry at the α position corresponds to R or S.

Description

광활성 α-아미노산의 제조방법Method for preparing photoactive α-amino acid

본 발명은 광활성 α-아미노산의 제조방법에 관한 것이며, 보다 상세히는 하기 일반식(I)로 표시되는 α-아미노산 또는 그 유도체를 광활성적으로 제조하는 방법에 관한 것이다.The present invention relates to a method for producing photoactive α-amino acids, and more particularly, to a method for photoactively preparing α-amino acids or derivatives thereof represented by the following general formula (I).

단, 상기 식에서 R은 사슬형이나 고리형 알킬기 또는 이릴기이며, α위치의 입체화학은 R(D) 또는 S(L)에 해당한다.In which R is a chain or cyclic alkyl group or aryl group, and the stereochemistry at the α position corresponds to R (D) or S (L).

아미노산에는 천연단백질의 성분이되는 약 20개의 α 아미노산(common α-aminoacid)과 단백질의 구성성분이 아닌 약 700여개의 비단백질성 아미노산이 알려져 있다.Amino acids are known as about 20 α amino acids (common α-aminoacid) which are components of natural protein and about 700 nonproteinaceous amino acids which are not components of protein.

코몬(common) 아미노산은 효소를 포함한 모든 단백질의 조성에 필수적이며, 세포내의 신진대사체의 성분으로서 생명현상에 관여하고 있다. 아미노산의 유도체들은 신경전달물질로서, 효소억제제로서, 그리고 의약품, 농약품 등의 생리활성물질의 조성성분으로 그 유용성이 잘 알려져 있고, 복잡한 화합물의 합성에서 중간체, 전구체 또는 광활성 재료물질로서 사용될 수 있는 높은 응용성을 가지고 있다. (Topics in Current Chemistry, Springer-Verlag, Berlin, 1983, p66 및 1984, p167).Common amino acids are essential for the composition of all proteins, including enzymes, and are involved in life phenomena as components of metabolism in cells. Derivatives of amino acids are well known for their usefulness as neurotransmitters, enzyme inhibitors, and constituents of bioactive substances such as pharmaceuticals and pesticides, and can be used as intermediates, precursors or photoactive materials in the synthesis of complex compounds. It has high applicability. (Topics in Current Chemistry, Springer-Verlag, Berlin, 1983, p66 and 1984, p167).

아미노산의 제조에는 (1) 발효에 의한 방법, (2) 단백질의 가수분해에 의한 방법 (3) 효소를 이용한 합성방법 및 (4) 유기합성에 의한 방법이 널리 사용되고 있다. 방법(1)과 방법(3)에 의한 제조는 천연에 존재하는 아미노산에만 국한되고, 방법(4)에 의한 제조에는 광활성도가 높은 아미노산을 만들기가 용이하지 않다는 제한성이 있다. 그러나, 효소억제제, 항생제 및 생리활성물질의 선도체등에는 다양한 구조와 입체성을 가진 아미노산이 필요하므로 유기합성으로 광활성 아미노산을 제조하는 방법이 보다 중요시되고 있다.For the production of amino acids, (1) fermentation, (2) protein hydrolysis, (3) enzyme synthesis, and (4) organic synthesis are widely used. The production by methods (1) and (3) is limited to amino acids that exist in nature, and the production by methods (4) has a limitation that it is not easy to make amino acids with high photoactivity. However, since enzyme inhibitors, antibiotics, and leaders of physiologically active substances require amino acids having various structures and conformations, methods of preparing photoactive amino acids by organic synthesis are becoming more important.

광활성 아미노산을 합성적으로 제조하기 위해서는 1) 광활성이 없는 아미노산을 합성한 후 이를 광활성 분해하는 방법과 2) 처음부터 광활성 합성을 수행하는 방법을 이용할 수 있다. 첫 번째의 광활성 분해방법은 원하는 광활성 아미노산이 화합물의 절반밖에 되지 않는다는 경제성의 문제를 수반하고 있고, 두 번째의 광활성 합성방법에는 높은 광학적 수율을 얻기 어렵다는 기술적 문제가 존재한다.To synthesize photoactive amino acids, 1) a method of synthesizing non-photoactive amino acids and then photoactively decomposing them, and 2) a method of performing photoactive synthesis from the beginning. The first photoactive degradation method involves the problem of economics that the desired photoactive amino acid is only half of the compound, and the second photoactive synthesis method has a technical problem that it is difficult to obtain high optical yield.

α 아미노산의 구조를 합성하여 제조하기 위해서는, 1) 디하이드로아미노산의 수소 첨가반응, 2) 글라이신의 알킬화 반응, 3) α-아미네이션 반응 또는 4) α 카르복실화 반응등의 방법이 이론적으로 가능하다. (Synthesis of Optically Active α-Amino Acids, Pergamon Press, Oxford, 1989).In order to synthesize the structure of the α amino acid, the following methods are theoretically possible: 1) hydrogenation of dihydroamino acids, 2) alkylation of glycine, 3) α-amimination reaction, or 4) α carboxylation reaction. Do. Synthesis of Optically Active α-Amino Acids, Pergamon Press, Oxford, 1989.

본 발명의 목적은 분자내 α-아미네이션 반응을 이용하여 α-아미노산 또는 이의 유도체를 높은 광학수율로 제조하는 방법을 제공하는데에 있다.It is an object of the present invention to provide a method for producing α-amino acids or derivatives thereof in high optical yield using intramolecular α-amimination reactions.

본 발명에 의하면, 일반식(II)According to the present invention, general formula (II)

의 화합물을 용매의 존재하에 친전자체 시약을 사용하여 아미도 고리화 반응시켜 상기 일반식(II)의 화합물을 고리화시킨 후, 그 결과 생성된 물질을 환원시켜 친전자체 기능기를 제거하고, 산성조건하에서 가수분해시켜 α-아미노산을 얻음, 을 특징으로 하는 α-아미노산 제조방법이 제공된다.Of the compound of formula (II) by cyclization of the compound of Formula (II) by electrophilic reagent in the presence of a solvent, followed by reduction of the resulting material to remove the electrophilic functional groups, and acidic conditions. Hydrolysis under to obtain α-amino acid, a method for producing α-amino acid is provided.

단, 상기 식에서 A=B=H이거나, A-X-B부분이 포화되었거나 불포화된 접합된 탄소고리화합물이거나 헤테로고리 화합물이고; R은 알킬 또는 아릴기이며; Y는 CONH2, C≡N, CONHNH2, CON3, CONHSO2R'(단, R'는 알킬 또는 아릴이다), 또는 CONHOR(단, R는 알킬 또는 cbz이다)이며: α위치의 입체화학은 R 또는 S에 해당된다.Provided that A = B = H, wherein the A-X-B moiety is a saturated or unsaturated conjugated carbocyclic compound or heterocyclic compound; R is an alkyl or aryl group; Y is CONH2, C≡N, CONHNH2, CON3, CONHSO2R '(where R' is alkyl or aryl), or CONHOR (where R is alkyl or cbz): the stereochemistry at α Yes.

이하, 본 발명에 대하여 상세히 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.

본 발명에서는 프롤린(proline)이나 그 유사체를 키랄(chiral)보조기로 사용하여 광활성을 갖는 α-아미노산을 높은 광학수율로 제조할 수 있는 방법이 제공된다.In the present invention, a method capable of producing photoactive alpha -amino acid with high optical yield using proline or an analog thereof as a chiral assistant is provided.

이같은 방법에 사용되는 중간물질은 상기 일반식(III)로 나타낼 수 있으며, 이는 부착된 반응기에 따라 달라질 것이다.The intermediate used in this process can be represented by the general formula (III) above, which will depend on the reactor attached.

이하, 본 발명의 방법을 설명한다. 다만 편의를 위해 상기 일반식에서 Y가 CoNH2인 경우, 즉 상기 식 II의 화합물이 일반식The method of the present invention is described below. However, for the sake of convenience, when Y is CoNH 2 in the formula, that is, the compound of Formula II is

(이하, 단지 일반식II'라 한다)으로 나태내어지는 프롤린 유도체인 경우를 중심으로 설명한다.The following description will focus on the case of the proline derivative represented by the following (hereinafter simply referred to as general formula II ').

상기 일반식II'의 화합물은 A=B=H인 경우 L- 또는 D-프롤린을 출발물질로하여 아미노산과 펩타이드 화학 분야에서 잘 알려진 기술을 통해 여러 가지 α,β-불포화카르복실산과 축합시켜 제조할 수 있다.The compound of Formula II ′ is prepared by condensation with various α, β-unsaturated carboxylic acids through well-known techniques in amino acid and peptide chemistry using L- or D-proline as a starting material when A = B = H. can do.

이와같은 일반신II'의 화합물은 카르복사미드(carboxamid)기를 그대로 혹은 N,O-비스사일릴 에테르로 바꾼 상태에서 친전자체 시약과 반응시켜 아미도 고리화 반응에 의해 식IIISuch a compound of general cine II 'is reacted with an electrophile reagent by changing a carboxamid group as it is or with N, O-bissilyl ether, and then reacted with an amido cyclization reaction to form III.

화합물을 생성시킨다.To yield the compound.

친전자체 시약 E+의 예로서는 Br2, I2, Hg2+, RSe+(여기서 R은 알킬 또는 아릴이다) 또는 RS+(R은 알킬 또는 아릴)을 포함한다.Examples of electrophilic reagent E + include Br2, I2, Hg2 +, RSe +, where R is alkyl or aryl, or RS + (R is alkyl or aryl).

상기 아미도고리화 반응은 용매의 존재하에 -20℃∼150℃온도범위에서 수행가능하나 -20℃∼50℃온도에서 수행하는 것이 바람직하다. 사용가능한 용매로는 CH2Cl2, CH3CN, DMF 및 벤젠 등을 들 수 있으나, 그이외에도 이 분야에서 사용하는 어떠한 종류의 용매라도 사용가능하다.The amidocyclic reaction can be carried out at a temperature range of -20 ° C to 150 ° C in the presence of a solvent, but is preferably performed at a temperature of -20 ° C to 50 ° C. Solvents that can be used include CH2Cl2, CH3CN, DMF, benzene and the like, but any other solvent used in this field may be used.

또한 상기 고리화반응은 광을 포함하는 촉매의 존재하에서 또는 촉매없이 수행할수 있다.The cyclization can also be carried out in the presence or absence of a catalyst comprising light.

상기 식 III의 화합물에서 A=B=H인 경우 α'위치의 입체화학은 출발물질중 하나인 프롤린의 α위치의 입체화학에 의존한다.When A = B = H in the compound of Formula III, the stereochemistry of the α ′ position depends on the stereochemistry of the α position of proline, which is one of the starting materials.

예컨데, L-프롤린으로부터 유도된 화합물(III)에서 α위치의 입체화학은 S(L)이고 α'위치의 입체화학은 주로 R(D)인 것과 D-프롤린으로부터 유도된 화합물(III)에서 α위치의 입체화합은 R(D)이고, α'위치의 입체화학은 주로 S(L)임이 본 발명에서 밝혀졌다. 따라서 본 발명에서 이용된 화합물(II)의 아미도고리화반응에서의 [1,4]-키랄리티 유도는 L→D 또는 D→L인 것으로 나타났다.For example, the stereochemistry at the α position in compound (III) derived from L-proline is S (L) and the stereochemistry at the α ′ position is mainly R (D) and α in compound (III) derived from D-proline. It has been found in the present invention that the stereosynthesis of the position is R (D) and the stereochemistry of the α 'position is mainly S (L). Therefore, the induction of [1,4] -chirality in the amidocyclic reaction of compound (II) used in the present invention was found to be L → D or D → L.

아미도고리화 반응에 의해 생성된 식 III의 화합물은 그후 친전자체기 E+를 제거하기 위해 환원되며 그 생성물을 산성조건하에서 가수분해함으로써 일반식(I)의 광활성 α-아미노산을 얻을 수 있는 것이다.The compound of formula III produced by the amidocyclization reaction is then reduced to remove the electrophilic group E + and the product is hydrolyzed under acidic conditions to obtain the photoactive α-amino acids of general formula (I).

광활성의 순도는 일반식(III)으로 표시된 화합물에서 NMR기법으로 결정하거나, α-아미노산(1)의 광학 로테이션을 포라리메터방법으로 결정할 수 있다. A=B=H인 경우, 가수분해에서 분산물로 얻어진 프롤린은 화합물(II)(A=B=H)의 제조에 재사용될 수 있다.The purity of the photoactivity can be determined by the NMR technique in the compound represented by the general formula (III), or the optical rotation of the α-amino acid (1) can be determined by the Porraram method. When A = B = H, the proline obtained as a dispersion in hydrolysis can be reused for the preparation of compound (II) (A = B = H).

일반식 II'로부터 광활성 α-아미노산을 제조하는 방법에 대하여 설명하였으나 이 제조과정은 일련의 반응식으로 표시하면 다음과 같다.The method for preparing the photoactive α-amino acid from the general formula II 'has been described, but the preparation process is as follows.

상기한 바는 일반식 II에서 Y가 -CONH2인 경우인 일반식 II'에 대하여 설명하였으나 이는 단지 예시한 것에 불과하며, Y가 C≡N, CONHNH2, CON3, CONHSO2R', CONHOR인 경우등에도 그대로 적용될 수 있는 것이다.The above description has been made for the general formula II 'in which Y is -CONH2 in general formula II, but this is merely illustrative, and the same is true even when Y is C≡N, CONHNH2, CON3, CONHSO2R', or CONHOR. It can be applied.

이하, 본 발명의 실시예에 대하여 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, the Example of this invention is described.

다만 본 실시예는 본 발명의 방법을 단지 예시한 것으로써 결코 본 발명의 범위를 제한하는 것으로 해석되어서는 안된다.However, this embodiment is only illustrative of the method of the present invention and should not be construed as limiting the scope of the present invention.

[실시예1]Example 1

1) 페닐알리닌의 제조1) Preparation of Phenylalanine

단계1. (S)-N-신나모일프롤린의 합성Step 1. Synthesis of (S) -N-cinnamoylproline

L-프롤린(1.15g)을 2N-NaOH(6ml)에 녹인 후 0℃에서 아세톤(6ml)으로 희석시켰다. 신나모일 클로라이드(1.67g)를 아세톤(7ml)과 2N-NaOH(7ml)에 녹여 0℃에서 상기프롤린 용액에 교반하면서 천천히 적가하였다. 상온에서 반응혼합물을 6시간동안 교반한 후 감압증류로 아세톤을 제거하였다. 남은 용액을 에테르로 씻고 농축 HCl로 pH를 2로 조정하였다. 산성화된 반응혼합물을 에틸아세테이트로 추출한 후 유기층을 식염수와 증류수로 여러번 씻고 감압증류하여 생성물 2.3g을 얻었으며 이를 CH3OH에서 재결정하여 순수한 (S)-N-신나모일프롤린을 1.732g 얻었다.L-proline (1.15 g) was dissolved in 2N-NaOH (6 ml) and diluted with acetone (6 ml) at 0 ° C. Cinnamoyl chloride (1.67 g) was dissolved in acetone (7 ml) and 2N-NaOH (7 ml) and slowly added dropwise to the proline solution at 0 ° C. with stirring. After stirring the reaction mixture at room temperature for 6 hours, acetone was removed by distillation under reduced pressure. The remaining solution was washed with ether and the pH was adjusted to 2 with concentrated HCl. The acidified reaction mixture was extracted with ethyl acetate, and then the organic layer was washed several times with brine and distilled water and distilled under reduced pressure to obtain 2.3 g of the product, which was recrystallized from CH3OH to obtain 1.732 g of pure (S) -N-cinnaylylproline.

mp 175.6℃mp 175.6 ℃

α]D=+11.52。(c=0.13, CH2CL2)α] D = +11.52。 (c = 0.13, CH 2 CL 2 )

1H-NMR(CDCl3.D2O)δ1.99-2.54(4H, m), 3.64-3.82(2H,m), 4.74(1H, br.d), 6.71(1H,D,J=15.4Hz), 7.26-7.56(5H,m), 7.82(1H,d,j=15.4Hz) 1 H-NMR (CDCl 3 .D 2 O) δ 1.99-2.54 (4H, m), 3.64-3.82 (2H, m), 4.74 (1H, br.d), 6.71 (1H, D, J = 15.4 Hz), 7.26-7.56 (5H, m), 7.82 (1H, d, j = 15.4 Hz)

단계2. (S)-N-신나모일프롤린아마이드의 합성Step 2. Synthesis of (S) -N-cinnaylylprolineamide

단계1에서 제조한 (S)-N-신나모일프롤린(718mg)과 트리이에틸아민(0.45ml)을 CH2Cl2(100ml)에 녹인 후 얼음통에 넣어 -20℃정도로 유지하였다. 아이소뷰틸클로로포르메이트(411mg)를 한방울씩 첨가하고 1시간이 지난 후 NH4OH(29.7%, 5ml)을 적가하였다. 이산화탄소가 발생한 후 이 온도에서 30분, 상온에서 2시간을 교반하였다. 유기용매를 감압증류하여 제거하고, 남은 반응물을 1N-HCl로 중성화한 후 다시 감압증류하고, 물에서 재결정하여 흰색의 고체 601mg을 얻었다.(S) -N-cinnamoylproline (718 mg) and triethylamine (0.45 ml) prepared in step 1 were dissolved in CH 2 Cl 2 (100 ml), and then placed in an ice bucket and maintained at -20 ° C. Isobutylchloroformate (411 mg) was added dropwise and after 1 hour, NH 4 OH (29.7%, 5 ml) was added dropwise. After the generation of carbon dioxide, the mixture was stirred at this temperature for 30 minutes and at room temperature for 2 hours. The organic solvent was removed by distillation under reduced pressure, and the remaining reaction product was neutralized with 1N-HCl, and further distilled under reduced pressure, and recrystallized from water to obtain a white solid (601 mg).

mp 171-2℃mp 171-2 ℃

α]D=-17.98°(c=1.11, CH3OH)α] D = -17.98 ° (c = 1.11, CH 3 OH)

1H-NMR(CDCL3)δ 2.03-2.52(4H, m), 3.63-3.81(2H,m), 4.75(1H, br.d), 5.47(1H,br), B.73(1H,d,J=15.4Hz), 7.26(1H,br), 7.35-7.55(5H,m), 7.77(1H,d,J=15.4Hz) 1 H-NMR (CDCL 3 ) δ 2.03-2.52 (4H, m), 3.63-3.81 (2H, m), 4.75 (1H, br.d), 5.47 (1H, br), B.73 (1H, d , J = 15.4 Hz), 7.26 (1H, br), 7.35-7.55 (5H, m), 7.77 (1H, d, J = 15.4 Hz)

단계3. (S)-N-신나모일프롤린아마이드의 고리화 반응Step 3. Cyclization Reaction of (S) -N-cinnaylylprolineamide

(방법1) (S)-N-신나모일프롤린아마이드(108mg)과 트리이에틸아민(0.14ml)을 CH2Cl2(10ml)에 녹인 후 촉매량의 4-디메틸아미노파리딘과 트리메틸사일릴 트리플레이트(0.18ml)을 첨가하고 Ar하에서 2시간동안 교반하였다. 유기물을 감압증류하여 제거한 뒤 에테르를 사용하여 생성물을 추출하였다. 이를 아세토나이트릴(7ml)에 녹이고 페닐셀테니움 브로마이드(110mg)를 첨가하고 상온에서 7시간동안 교반하였다. 이 용액에 10% Na2SO3(10ml)과 10% NaHCO3(20ml)을 가하고 CH2Cl2로 추출하였다. 추출액은 감압증류로 농축하고 생성물을 판크로마토그라피(SiO2)를 통해 페닐셀레니움을 가진 고리화 화합물을 110mg얻었다.Method 1 After dissolving (S) -N-cinnamoylprolineamide (108 mg) and triethylamine (0.14 ml) in CH 2 Cl 2 (10 ml), catalytic amounts of 4-dimethylaminoparadine and trimethylsilyl triflate (0.18 ml ) Was added and stirred for 2 h under Ar. The organics were removed by distillation under reduced pressure and the product was extracted using ether. This was dissolved in acetonitrile (7 ml), phenylseltenium bromide (110 mg) was added, and stirred at room temperature for 7 hours. To this solution was added 10% Na 2 SO 3 (10 ml) and 10% NaHCO 3 (20 ml) and extracted with CH 2 Cl 2. The extract was concentrated under reduced pressure distillation and the product was obtained by 110 mg of cyclized compounds having phenyl selenium through panchromatography (SiO 2).

mp 218-220℃mp 218-220 ℃

α]D+177。(c=1.06, CHCl3)α] D +177。 (c = 1.06, CHCl 3 )

1H-NMR(CDCL3)δ 1.65-1.84(CH, m), 2.58-2.61(1H,m), 3.61(2H, t), 4.21(1H, d, J=8.9Hz), 4.72(1H,d,J=8.9Hz*, 4.83(1H,br,d), 6.19(1H,br), 7.06-7.37(10H,m)δ4.21(d)과 4.32(d)의 피크비율은 17.6대 1.0으로 나타났고 이에 해당하는 de는 약 90%로 계산된다. 1 H-NMR (CDCL 3 ) δ 1.65-1.84 (CH, m), 2.58-2.61 (1H, m), 3.61 (2H, t), 4.21 (1H, d, J = 8.9Hz), 4.72 (1H, d, J = 8.9Hz *, 4.83 (1H, br, d), 6.19 (1H, br), 7.06-7.37 (10H, m) The peak ratios of 4.21 (d) and 4.32 (d) are 17.6 to 1.0 De corresponds to about 90%.

MS(FAB)m/z 400(M+1)MS (FAB) m / z 400 (M + 1)

(방법2) (S)-N-신나모일프롤린아마이드(120mg)과 DMF(370mg)을 CH3CN(10ml)에 녹인 후 AgOTf(384mg)와 페닐셀레니움 브로마이드(354mg)을 첨가하고, 상온 Ar하에서 16시간 교반하였다. 방법1에서 같은 절차를 거쳐 페닐셀레니움을 가진 고리화합물을 162mg얻었다. 생성물의 물리적, 화학적 성질은 방법1에서 얻은 것과 동일하였다.(Method 2) (S) -N-cinnaylylprolineamide (120 mg) and DMF (370 mg) were dissolved in CH3CN (10 ml), AgOTf (384 mg) and phenyl selenium bromide (354 mg) were added, and the mixture was kept at room temperature Ar for 16 hours. Stirred. In the same manner as in Method 1, 162 mg of a cyclic compound having phenyl selenium was obtained. The physical and chemical properties of the product were the same as those obtained in Method 1.

단계4. D-페닐알라닌 메틸에스테르의 합성Step 4. Synthesis of D-phenylalanine Methyl Ester

단계3에서 얻은 고리화된 생성물(54mg)을 THF(6ml)에 녹이고 NiCl2. 6H2O(66mg)을 녹인 CH3OH(2ml)에 첨가하였다. 0℃로 냉각된 이용액에 NaBH4(8.5mg)을 적가하고, 상온, Ar하에서 2시간동안 교반하였다. 반응혼합물을 셀라이트를 통해 여과하고, 여과액을 감압증류한 후 약 32mg의 생성물을 얻었다.The cyclized product (54 mg) obtained in step 3 was dissolved in THF (6 ml) and dissolved in NiCl 2. 6H 2 O (66 mg) was added to the dissolved CH 3 OH (2 ml). NaBH 4 (8.5 mg) was added dropwise to the solution cooled to 0 ° C., and stirred for 2 hours at room temperature and under Ar. The reaction mixture was filtered through celite and the filtrate was distilled under reduced pressure to obtain about 32 mg of product.

1H-NMR(CDCl3)δ 1.65-1.86(3H, m), 2.58-2.64(1H,m), 3.10(1H, dd, J=14.5 7.6Hz), 3.30(1H, dd, J=14.5 5.3Hz), 4.25(1H,dd,J=7.6 5.3.Hz), 4.83(1H,br.d), 6.20(1H, br), 7.30-7.50(5H,m) 1 H-NMR (CDCl 3) δ 1.65-1.86 (3H, m), 2.58-2.64 (1H, m), 3.10 (1H, dd, J = 14.5 7.6 Hz), 3.30 (1H, dd, J = 14.5 5.3 Hz ), 4.25 (1H, dd, J = 7.6 5.3.Hz), 4.83 (1H, br.d), 6.20 (1H, br), 7.30-7.50 (5H, m)

위에서 얻은 생성물(31.2mg)을 6N-HCl(5ml)에 녹여 상온에서 1시간동안 교반한 후 pH를 7로 조정한 다음 동결건조(lyophilization)하였다. 생성된 D-페닐알라닌을 CH3OH에 녹이고 HCl(gas)로 처리한 후 판크로마토그라피(SiO2)를 통해 D-페닐알라닌 메틸에스테르(21mg)로 변환시켰다.The product obtained above (31.2 mg) was dissolved in 6N-HCl (5 ml), stirred at room temperature for 1 hour, the pH was adjusted to 7, and then lyophilized. The resulting D-phenylalanine was dissolved in CH 3 OH, treated with HCl (gas), and then converted into D-phenylalanine methyl ester (21 mg) through plate chromatography (SiO 2).

α]D-27.6。(c=0.445, EtOH);ee=86.0%α] D -27.6。 (c = 0.445, EtOH); ee = 86.0%

1H-NMR(D2O)δ 2.8(1H, dd, J=13.5 7.8Hz), 3.1(1H,dd,J=13.6 5.2Hz), 3.7(3H,S), 7.2-7.3(5H,m) 1 H-NMR (D 2 O) δ 2.8 (1H, dd, J = 13.5 7.8 Hz), 3.1 (1H, dd, J = 13.6 5.2 Hz), 3.7 (3H, S), 7.2-7.3 (5H, m )

[실시예2]Example 2

L 페닐알라닌의 제조Preparation of L Phenylalanine

단계1 및 2. (R)-N 신나모이리프롤린 및 (R)-N-신나모일프롤린아마이드의 합성Steps 1 and 2. Synthesis of (R) -N Cinnamoriproline and (R) -N-Cinnamoylprolineamide

실시예1의 단계1과 2에서 기술한 방법에 따라 D-프롤린을 출발물질로 하여 (R)-N-신나모일프롤린을 거쳐 (R)-N-신나모일프롤린아마이드를 합성하였다.According to the method described in steps 1 and 2 of Example 1, (R) -N-cinnamoylprolineamide was synthesized through (R) -N-cinnamoylproline as a starting material.

mp 171℃mp 171 ℃

α]D+17.6。(C=1.04, CH3OH)α] D +17.6。 (C = 1.04, CH 3 OH)

1H-NMR(CDCl3) 실시예1의 단계2에서 합성한 (S)-N-신나모일프롤린아마이드와 동일하였다. 1 H-NMR (CDCl 3 ) The same as (S) -N-cinnaylylprolineamide synthesized in step 2 of Example 1.

단계3. (R)-N-신나모일프롤린아마이드의 고리화반응Step 3. Cyclization Reaction of (R) -N-cinnaylylprolineamide

(R)-N-신나모일프롤린아마이드로부터 출발하여, 실시예1의 단계3(방법2)에 기술한 반응절차를 통하여 폐닐셀레니움을 가진 고리화합물을 얻었다.Starting from (R) -N-cinnamoylprolineamide, a cyclic compound having a spent nile selenium was obtained through the reaction procedure described in step 3 (method 2) of Example 1.

Mp 218-220℃Mp 218-220 ℃

α]D-171.6。(C=1.19, CHCl3)α] D -171.6。 (C = 1.19, CHCl 3 )

1H-NMR(CDCl3)δ 1.8-2.01(3H,m), 2.6-2.69(1H,m), 3.54-3.62(1H,m), 4.18-4.22(1H,m), 4.70-4.73(1H,m), 4,81-4.83(1H,m), 7.06-7.38(10H,m) 1 H-NMR (CDCl 3 ) δ 1.8-2.01 (3H, m), 2.6-2.69 (1H, m), 3.54-3.62 (1H, m), 4.18-4.22 (1H, m), 4.70-4.73 (1H , m), 4,81-4.83 (1H, m), 7.06-7.38 (10H, m)

MS(FAB) m/z 400(M+1)MS (FAB) m / z 400 (M + 1)

단계4. L페닐알라닌 메틸에스테르의 합성Step 4. Synthesis of Lphenylalanine Methyl Ester

단계3에서 얻은 고리화된 생성물을 실시예1의 단계4에서와 같은 방법으로 환원 및 가수분해하여 L-페닐알라닌을 얻었고, 이를 HCl(gas)와 CH3OH로 처리하여 L-페닐알라닌 메틸에스테르로 변환시켜 확인하였다.The cyclized product obtained in step 3 was reduced and hydrolyzed in the same manner as in step 4 of Example 1 to obtain L-phenylalanine, which was converted to L-phenylalanine methyl ester by treatment with HCl (gas) and CH3OH. It was.

α]D-29.5。(C=0.571, EtOH): ee=91.9%α] D -29.5。 (C = 0.571, EtOH): ee = 91.9%

1H-NMR(D2O)실시예1에서 얻은 D-페닐알라닌 메틸에스테르와 동일하였다. 1 H-NMR (D 2 O) The same as the D-phenylalanine methyl ester obtained in Example 1.

[실시예3]Example 3

(R)-2 아미노뷰틸산의 제조Preparation of (R) -2 Aminobutyl Acid

단계1. (S)N-크로토닐프롤린의 합성Step 1. Synthesis of (S) N-crotonylproline

L-프롤린(1.15g)을 2N-NaOH(6ml)에 녹이고 0℃에서 아세톤(6ml)로 희석시켰다. 크로토닐클로라이드(1.20g)를 아세톤(7ml)과 2N-NaOH(7ml)에 녹여 상기 용액에 천천히 적가하였다. 상온에서 반응혼합물을 16시간 교반한 후 감압증류하여 아세톤을 제거하였다. 남은 용액을 에테르로 씻어준 후 농축 HCl로 pH를 2에 조정하였다. 산성화된 반응물을 에틸아세테이트로 추출한 후, 유기추출액을 식염수와 증류수로 씻고, 감압증류하여 생성물(1.39g)을 얻었다.L-proline (1.15 g) was dissolved in 2N-NaOH (6 ml) and diluted with acetone (6 ml) at 0 ° C. Crotonyl chloride (1.20 g) was dissolved in acetone (7 ml) and 2N-NaOH (7 ml) and slowly added dropwise to the solution. The reaction mixture was stirred at room temperature for 16 hours and then distilled under reduced pressure to remove acetone. The remaining solution was washed with ether and then the pH was adjusted to 2 with concentrated HCl. The acidified reactant was extracted with ethyl acetate, and the organic extract was washed with brine and distilled water and distilled under reduced pressure to obtain a product (1.39 g).

mp 156-158℃mp 156-158 ℃

α]D60.37° (c=1.03, CH2Cl2)α] D 60.37 ° (c = 1.03, CH 2 Cl 2 )

1H-NMR(CDCl3-D2O)δ1.83(3H, dd), 2.0-2.06(3H,m), 2.33(1H,m), 3.51-3.66(2H,m), 4,60(1H,t), 6.11(1H,d,J 15.5Hz), 7.0(1H,m) 1 H-NMR (CDCl 3 -D 2 O) δ 1.83 (3H, dd), 2.0-2.06 (3H, m), 2.33 (1H, m), 3.51-3.66 (2H, m), 4,60 ( 1H, t), 6.11 (1H, d, J 15.5 Hz), 7.0 (1H, m)

단계2 (S)-N-크로토닐프롤린아마이드의 합성Step 2 Synthesis of (S) -N-crotonylprolineamide

위에서 만든(S)-N-크로토닐프롤린(915mg)과 트라이에틸아민(510mg)을 CH2Cl2(50ml)에 녹였다. 반응용액의 온도를 0℃로 냉각 시킨 후 아이소뷰틸클로로포르메이트(748mg)을 적가하고 1시간동안 교반하였다. 반응용액에 NH4OH(29.7%, 5ml)을 넣고 상온에서 6시간 교반하였다. CH2Cl2을 이용하여 생성물을 추출하였고, 유기용매를 감압증류하여 제거하였다. 관크로마토그라피(SiO2)를 통해 순수한 생성물(595mg)을 오일상으로 얻었다.(S) -N-crotonylproline (915 mg) and triethylamine (510 mg) made above were dissolved in CH 2 Cl 2 (50 ml). After cooling the temperature of the reaction solution to 0 ℃ isobutyl chloroformate (748mg) was added dropwise and stirred for 1 hour. NH 4 OH (29.7%, 5ml) was added to the reaction solution, and the mixture was stirred at room temperature for 6 hours. The product was extracted using CH 2 Cl 2 , and the organic solvent was removed by distillation under reduced pressure. Pure product (595 mg) was obtained in the oil phase via tube chromatography (SiO 2 ).

1H-NMR(CDCl3)δ1.95(3H, dd), 2.0-2.4(4H,m), 3.51(1H,m), 3.65(1H,m), 4.65(1H,d), 6.0(1H,br), 6.15(1H,d,J=14hz), 6.84(1H,m), 7.17(1H,br) 1 H-NMR (CDCl 3 ) δ 1.95 (3H, dd), 2.0-2.4 (4H, m), 3.51 (1H, m), 3.65 (1H, m), 4.65 (1H, d), 6.0 (1H , br), 6.15 (1H, d, J = 14hz), 6.84 (1H, m), 7.17 (1H, br)

단계3. (S)-N-크로토닐프롤린아마이드의 고리화반응Step 3. Cyclization Reaction of (S) -N-crotonylprolineamide

(S)-N-크로토닐프롤린아마이드(107mg)과 DMF(1.3g)을 CH3추(10ml)에 녹인 후, 페닐셀레니움 브로마이드(425mg)과 AgOTf(463mg)을 첨가하였다. 반응용액을 상온, Ar하에서 16시간 교반한 후 실시예1의 단계3에서와 같이 처리하여 페닐셀레니움을 가진 고리화 화합물을 152mg얻었다.(S) -N-crotonylprolineamide (107 mg) and DMF (1.3 g) were dissolved in CH 3 weight (10 ml), and then phenyl selenium bromide (425 mg) and AgOTf (463 mg) were added. The reaction solution was stirred at room temperature and under Ar for 16 hours, and then treated as in Step 3 of Example 1 to obtain 152 mg of a cyclized compound having phenyl selenium.

1H-NMR(CDCl3)δ1.05(3H,d,J=7Hz),1.60-1.81(3H,m),2.56-2.58(1H,m), 2.6(1H,m), 3.60(2H,t), 4.2(1H,d,J 8.5Hz), 4.82(1H,br.d), 2.6(1H), 6.25(1H,br), 7.10, 7.30(5H,m),δ4.2(d)과 4.3(d)의 피크(peak)비는 22대 1로 나타났고, 이에 해당하는 de=91.4%로 계산된다. 1 H-NMR (CDCl 3 ) δ1.05 (3H, d, J = 7Hz), 1.60-1.81 (3H, m), 2.56-2.58 (1H, m), 2.6 (1H, m), 3.60 (2H, t), 4.2 (1H, d, J 8.5Hz), 4.82 (1H, br.d), 2.6 (1H), 6.25 (1H, br), 7.10, 7.30 (5H, m), δ4.2 (d) And peak ratio of 4.3 (d) was found to be 22 to 1, which is calculated as de = 91.4%.

MS(FAB) m/z=338(M+1)MS (FAB) m / z = 338 (M + l)

단계4. (R)-2-아미노부틸산의 합성Step 4. Synthesis of (R) -2-Aminobutyl Acid

단계3에서 얻은 고리화된 생성물(100mg)을 THF(5ml)에 녹이고 NiCl2·6H2O(143mg)을 녹인 CH3OH(5ml)에 첨가하고, 0℃로 냉각하였다. 반응용액에 NaBH4(72mg)을 적가한후, 상온 Ar하에서 4시간동안 교반하였다. 반응물을 셀라이트를 통해 여과한 후, 그 여과액을 감압중류하고, 관크로마토그리피(SiO2)를 이용하여, 생성물(45mg)을 얻었다.The cyclized product (100 mg) obtained in step 3 was dissolved in THF (5 ml) and NiCl 2 .6H 2 O (143 mg) was added to the dissolved CH 3 OH (5 ml) and cooled to 0 ° C. NaBH 4 (72 mg) was added dropwise to the reaction solution, followed by stirring for 4 hours at room temperature Ar. The reaction was filtered through celite, and the filtrate was concentrated under reduced pressure, and the product (45 mg) was obtained using tube chromatography (SiO 2).

1H-NMR(CDCl3)δ1.0(3H,t), 1.60-1.82(3H,m), 1.85(2H,m), 2.8(1H,m), 2.60(1H,m), 3.61(2H,t), 3.90(1H,t), 4.84(1H,t), 6.24(1H,br), δ3.90(t)과 3.80(t)의 피크 비율은 21대1로 나타났고, 이는 de=91%에 해당한다. 1 H-NMR (CDCl 3 ) δ1.0 (3H, t), 1.60-1.82 (3H, m), 1.85 (2H, m), 2.8 (1H, m), 2.60 (1H, m), 3.61 (2H , t), 3.90 (1H, t), 4.84 (1H, t), 6.24 (1H, br), δ 3.90 (t) and 3.80 (t) peak ratios were 21 to 1. It corresponds to 91%.

위에서 얻은 생성물(27mg)을 6N HCl(3mm)에 녹이고 상온에서 1시간동안 교반하였다. 용액의 pH를 7로 조정한 다음 동결건조 하였다. 생성물을 CH3OH(5ml)에 녹이고 0℃로 냉각한 다음 농축 H2SO4(1ml)을 적가하였다. 상온에서 3.5시간 교반한 다음 pH를 7-8로 조정하고 동결건조 하였다. 생성된 고체를 CH3OH에 녹여 여과하였고, 그 여과액을 감압증류하여 얻은 불순한 생성물을 크로마토그라피(Si2O)로 정제하여 2-아미노뷰틸산 메틸에스테르(16ml)을 얻었다. 2-아미노뷰틸산 메틸에스테르를 LiOH(6.4mg)과 함께 CH3OH(3ml)과 H2O(1ml)에 녹여 0℃에서 2.5시간동안 교반한 후 pH를 7로 조정하고 동결건조 하였다. 고체생성물을 CH3OH에 다시 녹여 여과하였으며 여과액을 동결건조하여 흰색의 고체 2-아미노뷰틸산을 얻었다.The obtained product (27mg) was dissolved in 6N HCl (3mm) and stirred at room temperature for 1 hour. The pH of the solution was adjusted to 7 and then lyophilized. The product was taken up in CH 3 OH (5 ml), cooled to 0 ° C. and concentrated H 2 SO 4 (1 ml) was added dropwise. After stirring at room temperature for 3.5 hours, the pH was adjusted to 7-8 and lyophilized. The resulting solid was dissolved in CH 3 OH, filtered, and the filtrate was purified by distillation under reduced pressure. The resulting impure product was purified by chromatography (Si 2 O) to obtain 2-aminobutyl acid methyl ester (16 ml). 2-aminobutyl acid methyl ester was dissolved in CH 3 OH (3 ml) and H 2 O (1 ml) with LiOH (6.4 mg), stirred at 0 ° C. for 2.5 hours, adjusted to pH 7, and lyophilized. The solid product was dissolved in CH 3 OH again and filtered, and the filtrate was lyophilized to obtain a white solid 2-aminobutyl acid.

α]D-7.14。(C=1.61, H2O)α] D -7.14。 (C = 1.61, H2O)

1H-NMR(D2O)δ1.0(3H,t), 1.9(2H,dq), 3.7(1H,t). 1 H-NMR (D 2 O) δ 1.0 (3H, t), 1.9 (2H, dq), 3.7 (1H, t).

13C-NMR(D2O,pH 5.1))δ176.1, 57.2, 25.0, 9.7 13 C-NMR (D 2 O, pH 5.1)) δ 176.1, 57.2, 25.0, 9.7

로테이션(rotation)에 근거한 광활성 순도는 ee-90%인 것으로 나타났다.The photoactive purity based on rotation was found to be ee-90%.

Claims (7)

일반식ⅢFormula III 의 화합물을 용매내에서 친전자체 시약과 아미도고리화 반응시켜 상기 일반식의 화합물을 고리화시킨 후, 그 결과 생성된 물질을 환원시켜 친전자체기능기를 제거하고, 산성조건하에서 가수분해시켜 하기 식 I의 α-아미노산을 얻음,을 특징으로 하는 광활성 α-아미노산 제조방법.The compound of Formula 1 is cyclized by an amidocyclic reaction with an electrophilic reagent in a solvent, and the resulting material is reduced to remove an electrophilic functional group and hydrolyzed under acidic conditions. A method for producing a photoactive α-amino acid, characterized by obtaining α-amino acid of I. 단, 상기 식에서 A=B=H이거나, A-X-B부분이 포화되었거나 불포화된 탄소고리 화합물이거나 헤테로고리화합물이며,Provided that A = B = H, or the A-X-B moiety is a saturated or unsaturated carbocyclic compound or a heterocyclic compound, R은 알킬 또는 아릴기이며, Y는 -CONH2, C≡N, CONHNH2, CON3, CONHSO2R'(단, R'는 알킬 또는 아릴이다), 또는 CONHOR(단 R는 알킬 또는 Cbz이다)이며, α위치의 입체화학은 R 또는 S에 해당된다.R is an alkyl or aryl group, Y is -CONH 2 , C≡N, CONHNH 2 , CON 3 , CONHSO 2 R '(where R' is alkyl or aryl), or CONHOR (where R is alkyl or Cbz ) And the stereochemistry at the α position corresponds to R or S. 단, 식 I에서 R은 사슬형이거나 고리형알킬기 또는 아릴기이며, α위치의 입체 화학은 R(D) 또는 S(L)에 해당한다.With the proviso that R in formula I is a chain or cyclic alkyl group or an aryl group, and the stereochemistry at the α position corresponds to R (D) or S (L). 1항에 있어서, 상기 일반식II 화합물은 일반식II'According to claim 1, wherein the general formula II compound is Formula II ' 를 가지며, L- 또는 D-플롤린을 α,β-불포화 카르복실산과 축합시켜 제조된 것임을 특징으로 하는 α-아미노산 제조방법And a method for producing α-amino acid, characterized in that it is prepared by condensing L- or D-proline with α, β-unsaturated carboxylic acid. (단, 상기식에서 A=B=H이며, R은 앞에서 규정한 바와같다)(Wherein A = B = H and R is as defined above) 2항에 있어서, 상기 일반식II'의 화합물은 N-신나모일프롤린 아마이드이며, 상기 α-아미노산은 페닐알라닌 메틸에스테르임을 특징으로 하는 α-아미노산 제조방법.The method of claim 2, wherein the compound of Formula II 'is N-cinnamoylproline amide, and the α-amino acid is phenylalanine methyl ester. 2항에 있어서, 상기 일반식II'의 화합물은 N-크로토닐 프롤린아미이드이며, 상기 α-아미노산은 2-아미노뷰틸산임을 특징으로 하는 α-아미노산제조방법.The method of claim 2, wherein the compound of Formula II 'is N-crotonyl prolineamide, and the α-amino acid is 2-aminobutyl acid. 1항에 있어서, 상기 친전자체시약은 Br2, I2, Hg2+, RSe+(여기서 R은 알킬 또는 아릴기이다) 또는 RS+(여기서 R은 알킬 또는 아릴기이다)로 구성되는 그룹에서 선택됨을 특징으로 하는 α-아미노산 제조방법.The method of claim 1, wherein the electrophilic reagent is selected from the group consisting of Br 2 , I 2 , Hg 2+ , RSe + (where R is an alkyl or aryl group) or RS + (where R is an alkyl or aryl group) Α-amino acid production method characterized in that. 1항에 있어서, 상기 용매는 CH2Cl2, CH3CN, DMF 및 벤젠으로구성되는 그룹에서 선택됨을 특징으로 하는 α-아미노산 제조방법.The method of claim 1, wherein the solvent is selected from the group consisting of CH 2 Cl 2 , CH 3 CN, DMF, and benzene. 1항 내지 6항에 있어서, 상기 고리화반응은 -20℃∼50℃온도에서 수행됨을 특징으로 하는 α-아미노산 제조방법.The method of claim 1, wherein the cyclization reaction is α-amino acid production method, characterized in that carried out at -20 ℃ to 50 ℃ temperature.
KR1019940040275A 1994-12-31 1994-12-31 PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID KR0140323B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940040275A KR0140323B1 (en) 1994-12-31 1994-12-31 PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940040275A KR0140323B1 (en) 1994-12-31 1994-12-31 PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID

Publications (2)

Publication Number Publication Date
KR960022447A KR960022447A (en) 1996-07-18
KR0140323B1 true KR0140323B1 (en) 1998-07-01

Family

ID=19406074

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940040275A KR0140323B1 (en) 1994-12-31 1994-12-31 PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID

Country Status (1)

Country Link
KR (1) KR0140323B1 (en)

Also Published As

Publication number Publication date
KR960022447A (en) 1996-07-18

Similar Documents

Publication Publication Date Title
US4716235A (en) Process for preparing N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline
RU1797607C (en) Process for preparing [@]-@@@-ethyl-2-oxo-1-pyrrolidine acetamide
ES2472240T3 (en) Procedure for the preparation of benzoxazine derivatives and their intermediates
JP2005509028A (en) Process for the synthesis of aspartic and glutamic acid derivatives and their diazoketone intermediates
KR0140323B1 (en) PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID
US5446166A (en) Preparation of pyrrol and oxazole compounds: formation of porphyrins and C-acyl-α-amino acid esters therefrom
EP1554235B1 (en) Process for synthesizing l-y-methylene glutamic acid and analogs
US20030153771A1 (en) Large scale synthesis of optically pure aziridines
US20040039224A1 (en) T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them
KR20050092398A (en) Synthesis of (r) and (s)-aminocarnitine and derivatives thereof from d-and l-aspartic acid
CN86108424A (en) The synthetic method of nizatidine
CN111825594B (en) (Z) -beta-trifluoromethyl dehydrotryptophan compound and synthetic method and application thereof
US5959141A (en) 1-amino-2-hydroxycycloalkanecarboxylic acid derivatives
JPWO2008004415A1 (en) 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylates, process for producing the same and use thereof
JP4187822B2 (en) Process for producing optically active 4-hydroxy-2-pyrrolidone
JP4524845B2 (en) Method for producing optically active allyl alcohol derivative having amino group, and optically active compound
KR100645371B1 (en) Bicyclic tetrahydrofuran derivatives, and process for preparing them
JP3828197B2 (en) Process for producing optically active alkali metal salt of 3- (p-methoxyphenyl) glycidic acid
KR20000065816A (en) Novel process for synthesizing para- and/or meta-substituted cyanophenylalanine derivatives
KR0150566B1 (en) A process for preparing stereo active 3-amino heterocyclic compound
ES2400484T3 (en) A process for the preparation of isoserine derivatives
KR20160008873A (en) Novel beta-sulfinamino malonate derivatives and process for preparing the same, and process for preparing sitagliptin using the same
KR100255040B1 (en) Process for preparing D-(-)-pantolacton with amino acid silyl ester
CN116162057A (en) Preparation method of 5-sulfonyl-1, 4 dihydropyridine compound
JP2005082572A (en) Optically active cyclic amino acid derivative, its intermediate and their manufacturing methods

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030304

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee